Resources
Filter By
Resource Type
Therapeutic Area
January 11, 2023 | Blog
Importance of PI3K-AKT pathway-based biomarkers in breast cancer
biomarkers in breast cancer
Breast cancer
PI3K-AKT pathway
December 7, 2022 | Blog
The Prevalence and Outcomes of ESR1 Mutations in Breast Cancer
Breast cancer
ESR1 mutations
November 29, 2022 | Video
Advancing care & management of patients with HPV driven head & neck cancers
HPV
OPSCC
November 1, 2022 | Publication|INT J RADIAT ONCOL BIOL PHYS
Cell-Free HPV DNA Kinetics Predicted by Radiographic Response in Locoregional Viral-Associated Oropharyngeal Cancer Receiving Response-Adaptive Treatment – Exploratory Analysis of a Prospective Trial
HPV
OPC
November 1, 2022 | Publication|Int J Radiat Oncol Biol Phys
Individualized Treatment Responsiveness as Quantified by Dynamic Changes in Cell Free HPV DNA in Patients Receiving Induction Chemotherapy and Definitive Chemoradiation for HPV-Related Head and Neck Cancer
HNC
HPV
August 4, 2022 | Blog
Key differences between HPV-positive and HPV-negative head and neck squamous cell carcinomas (HNSCC)
HNSCC
HPV
HPV 16
HPV 18
June 2, 2022 | Publication|J Clin Oncol
Dynamic cell free HPV DNA is an early measure of treatment responsiveness in patients receiving induction chemotherapy for HPV-related head and neck cancer.
HNC
HPV
April 1, 2022 | Publication|INT J RADIAT ONCOL BIOL PHYS
Evaluation of Cell-Free HPV DNA in Patients With HPV-Associated Oropharyngeal Cancer Treated With Induction Chemotherapy and Response-Adaptive Therapy
HPV
OPC
January 3, 2022 | Publication|BMC Cancer
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment
HPV
OPC
May 28, 2021 | Publication|J Clin Oncol
Ultra-sensitive detection and quantification of HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial.
HPV
OPSCC